BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8212013)

  • 1. Direct suppression of superantigen-induced IgM secretion in human lymphocytes by 2,3,7,8-TCDD.
    Wood SC; Holsapple MP
    Toxicol Appl Pharmacol; 1993 Oct; 122(2):308-13. PubMed ID: 8212013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 7,12-dimethylbenz[a]anthracene on the superantigen toxic shock syndrome toxin (TSST-1)-induced proliferation and antibody secretion by human lymphocytes.
    Wood SC; Holsapple MP
    Fundam Appl Toxicol; 1993 Apr; 20(3):280-7. PubMed ID: 8504901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxic shock syndrome: characterization of human immune responses to TSST-1 and evidence for sensitivity thresholds.
    Kimber I; Nookala S; Davis CC; Gerberick GF; Tucker H; Foertsch LM; Dearman RJ; Parsonnet J; Goering RV; Modern P; Donnellen M; Morel J; Kotb M
    Toxicol Sci; 2013 Jul; 134(1):49-63. PubMed ID: 23640863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) elevates basal B-cell intracellular calcium concentration and suppresses surface Ig- but not CD40-induced antibody secretion.
    Karras JG; Morris DL; Matulka RA; Kramer CM; Holsapple MP
    Toxicol Appl Pharmacol; 1996 Apr; 137(2):275-84. PubMed ID: 8661353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of IgE synthesis by staphylococcal toxic shock syndrome toxin-1 in peripheral blood mononuclear cells from patients with atopic dermatitis.
    Hofer MF; Lester MR; Schlievert PM; Leung DY
    Clin Exp Allergy; 1995 Dec; 25(12):1218-27. PubMed ID: 8821303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The staphylococcal toxic shock syndrome toxin 1 triggers B cell proliferation and differentiation via major histocompatibility complex-unrestricted cognate T/B cell interaction.
    Mourad W; Scholl P; Diaz A; Geha R; Chatila T
    J Exp Med; 1989 Dec; 170(6):2011-22. PubMed ID: 2584933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell response to superantigen restimulation during menstrual toxic shock syndrome.
    Rasigade JP; Thomas D; Perpoint T; Peyramond D; Chidiac C; Etienne J; Vandenesch F; Lina G; Ferry T
    FEMS Immunol Med Microbiol; 2011 Aug; 62(3):368-71. PubMed ID: 21492259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staphylococcal cell membrane antigen, a possible antigen in post-methicillin resistant Staphylococcus aureus (MRSA) infection nephritis and IgA nephropathy, exhibits high immunogenic activity that is enhanced by superantigen.
    Shimizu Y; Sakurai H; Hirayama K; Seki M; Yoh K; Yamagata K; Koyama A
    J Nephrol; 2005; 18(3):249-56. PubMed ID: 16013011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and corticosteroid on in vitro lymphocyte maturation.
    Luster MI; Germolec DR; Clark G; Wiegand G; Rosenthal GJ
    J Immunol; 1988 Feb; 140(3):928-35. PubMed ID: 3257509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The superantigen toxic shock syndrome toxin-1 induces CD40 ligand expression and modulates IgE isotype switching.
    Jabara HH; Geha RS
    Int Immunol; 1996 Oct; 8(10):1503-10. PubMed ID: 8921429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissection of the function of HLA class II and costimulation in B cell-mediated and toxic shock syndrome toxin-1-induced T cell proliferation.
    Dennig D; O'Reilly RJ
    J Immunol; 1993 Jun; 150(12):5231-40. PubMed ID: 7685791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxic shock syndrome toxin-1-induced death is prevented by CTLA4Ig.
    Saha B; Jaklic B; Harlan DM; Gray GS; June CH; Abe R
    J Immunol; 1996 Nov; 157(9):3869-75. PubMed ID: 8892617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superantigen-primed T cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) replicate poorly following recall encounter.
    Faulconer L; Camacho I; Nagarkatti M; Nagarkatti PS
    Arch Toxicol; 2006 Mar; 80(3):134-45. PubMed ID: 16189661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1.
    Miethke T; Duschek K; Wahl C; Heeg K; Wagner H
    Eur J Immunol; 1993 Jul; 23(7):1494-500. PubMed ID: 8325325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the biological activities of toxic shock syndrome toxin-1: II. Induction of the proliferative response and the interleukin 2 production by T cells from human peripheral blood mononuclear cells stimulated with the toxin.
    Uchiyama T; Kamagata Y; Yan XJ; Kohno M; Yoshioka M; Fujikawa H; Igarashi H; Okubo M; Awano F; Saito-Taki T
    Clin Exp Immunol; 1987 Jun; 68(3):638-47. PubMed ID: 3498581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on human tonsillar lymphocytes.
    Wood SC; Jeong HG; Morris DL; Holsapple MP
    Toxicology; 1993 Jul; 81(2):131-43. PubMed ID: 8378939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of calcium-dependent B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Karras JG; Holsapple MP
    Toxicol Appl Pharmacol; 1994 Apr; 125(2):264-70. PubMed ID: 8171434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of murine T cells by toxic shock syndrome toxin-1. The toxin-binding structures expressed on murine accessory cells are MHC class II molecules.
    Uchiyama T; Tadakuma T; Imanishi K; Araake M; Saito S; Yan XJ; Fujikawa H; Igarashi H; Yamaura N
    J Immunol; 1989 Nov; 143(10):3175-82. PubMed ID: 2509554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engagement of MHC-class II molecules by staphylococcal exotoxins delivers a comitogenic signal to human B cells.
    Fuleihan R; Mourad W; Geha RS; Chatila T
    J Immunol; 1991 Mar; 146(5):1661-6. PubMed ID: 1847171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A kinetic comparative study on lymphocyte responses to superantigen and phytohemagglutinin: reciprocal presentation of superantigen on the surface of activated lymphocytes.
    Ijichi S; Yamano Y; Osame M; Hall WW
    Cell Immunol; 1996 Nov; 173(2):312-6. PubMed ID: 8912892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.